Latest News
Feature
How much difference will Eli Lilly’s half-price insulin make?
Lilly’s move on Humalog could put pressure on the other two big makers of insulin to act.
From the Journals
Bariatric surgery leads to less improvement in black patients
Black patients who underwent bariatric surgery suffered more overall complications and reported a lower quality of life than white patients.
From the Journals
More sleep can help youth manage type 1 diabetes
More sleep can lead to better glycemic control in youth with type 1 diabetes mellitus.
Conference Coverage
HCV treatment with DAA regimens linked to reduced diabetes risk
Diabetes incidence was lower in hepatitis C patients treated with DAAs than in untreated patients.
From the Journals
Umbilical cord allograft may boost diabetic foot ulcer healing
Persistent wounds treated with dehydrated human umbilical cord allograft had higher rates of complete healing at 12 weeks, compared with wounds...
News
Scott Gottlieb to step down as FDA commissioner
Scott Gottlieb, MD, will be stepping down from his post as commissioner of the Food and Drug Administration in about a month.
From the Journals
Behavioral intervention improves physical activity in patients with diabetes
Regular sessions with an exercise specialist could yield significant improvements in physical activity in patients with type 2 diabetes.
From the Journals
Groups of physicians produce more accurate diagnoses than individuals
Diagnostic accuracy is highest in groups of physicians, compared with individuals and even specialists.
Feature
Drug pricing does not inspire Americans’ trust
Pharmaceutical companies are trusted to create new drugs but not to price them fairly, survey shows.
Conference Coverage
Dermatologists name isobornyl acrylate contact allergen of the year
WASHINGTON – The adhesive ingredient is used in diabetes devices such as insulin pumps.
News
FDA approves label extension for dapagliflozin
The label extension means a broader population with type 2 diabetes and impaired renal function could benefit from treatment with dapagliflozin....